Advertisement China-Biotics Gets GMP Approval For New Qingpu Production Facility - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

China-Biotics Gets GMP Approval For New Qingpu Production Facility

China-Biotics, a developer, manufacturer and distributor of probiotics products in China, has received good manufacturing process (GMP) approval from the Shanghai Food and Drug Administration (SHFDA) for its new production facility in Qingpu Industrial Park.

China-Biotics said that with this certificate, China-Biotics’ new Qingpu facility is manufacturing all probiotic products under the nation’s strict GMP standard. This certificate is valid through March 28, 2013 and is renewable.

China-Biotics’s Qingpu facility features a 150 metric ton annual production capacity with production expected to reach a run rate of 75 metric tons by the end of 2010.

Jinan Song, chairman and CEO of China-Biotics, said: “We are excited that our new facility, featuring our own proprietary fermentation technologies and highly automated processing modules, has met the stringent requirements of the SFDA and it serves as a testament to our production management and quality control.

“GMP approval for probiotic products is one of the prerequisite metrics for a supplier to major diary producers in China. As probiotics are increasingly used in yogurt and milk powder in China, we now look forward to ramping up our commercial production to meet the growing demand for probiotic products nationwide.”